Nan Fung Group Holdings
KAI TAK, K3files as Nan Fung Group Holdings Ltd
$131m in 25 US stocks at the end of 30 June 2026. The top 10 are 82.4% of the money. It changed about 22.7% of the portfolio this quarter.
Value
$131m
Stocks
25
Top 10 share
82.4%
Turnover
22.7%
What changed this quarter
New
Bought for the first time this quarter.
- Ascendis Pharma A/SASND2.8% of the fund
- Chime FinancialCHYM0.3% of the fund
Added
Bought more of a stock they already held.
- Helus PharmaHELP5.0% of the fund+115%
Cut
Sold some of their stake.
- Oculis Holding AGOCS3.2% of the fund-14%
- Bolt BiotherapeuticsBOLT<0.1% of the fund-83%
Sold out
Sold their entire stake.
Holdings
- Helus PharmaHELP
- Share
- 5.0%
- Value
- $7m
- Shares
- 987,222
+115%
- Beone MedicinesONC
- Share
- 3.4%
- Value
- $4m
- Shares
- 15,722
Held
- Argenx SEARGX
- Share
- 2.0%
- Value
- $3m
- Shares
- 2,800
Held
- Ishares Ethereum TRETHA
- Share
- 0.5%
- Value
- $601,028
- Shares
- 50,549
Held
- Ishares Bitcoin Trust ETFIBIT
- Share
- 0.4%
- Value
- $531,575
- Shares
- 15,968
Held
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| MapLight TherapeuticsMPLT | 26.5% | $35m | 971,253 | Held |
| LB PharmaceuticalsLBRX | 15.6% | $20m | 630,657 | Held |
| EvommuneEVMN | 14.6% | $19m | 1,441,032 | Held |
| Helus PharmaHELP | 5.0% | $7m | 987,222 | +115% |
| IncyteINCY | 4.6% | $6m | 53,742 | Held |
| Rhythm PharmaceuticalsRYTM | 4.1% | $5m | 49,120 | Held |
| Beone MedicinesONC | 3.4% | $4m | 15,722 | Held |
| Oculis Holding AGOCS | 3.2% | $4m | 300,565 | -14% |
| Ascendis Pharma A/SASND | 2.8% | $4m | 13,600 | New |
| Revolution MedicinesRVMD | 2.7% | $4m | 19,253 | Held |
| Kymera TherapeuticsKYMR | 2.7% | $4m | 30,875 | Held |
| Madrigal PharmaceuticalsMDGL | 2.3% | $3m | 5,672 | Held |
| CelcuityCELC | 2.3% | $3m | 28,300 | Held |
| Acadia PharmaceuticalsACAD | 2.0% | $3m | 102,984 | Held |
| Argenx SEARGX | 2.0% | $3m | 2,800 | Held |
| Recursion PharmaceuticalsRXRX | 1.7% | $2m | 595,287 | Held |
| Procore TechnologiesPCOR | 1.6% | $2m | 53,299 | Held |
| Harmony Biosciences HoldingsHRMY | 0.7% | $984,854 | 27,049 | Held |
| InsmedINSM | 0.5% | $701,560 | 6,580 | Held |
| Ishares Ethereum TRETHA | 0.5% | $601,028 | 50,549 | Held |
| Ishares Bitcoin Trust ETFIBIT | 0.4% | $531,575 | 15,968 | Held |
| Chime FinancialCHYM | 0.3% | $431,616 | 21,075 | New |
| Rani Therapeutics HoldingsRANI | 0.3% | $375,321 | 493,584 | Held |
| Entrada TherapeuticsTRDA | 0.3% | $361,244 | 49,082 | Held |
| Bolt BiotherapeuticsBOLT | <0.1% | $19,250 | 5,000 | -83% |
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is up 107.3% since 30 June 2025.
Where the money is
Health care91.8%
Technology1.6%
Financial services0.3%
Other6.2%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.